The NCIC's behavioral initiative is comprised of three pillars, each of which is designed to make an important independent contribution toward a reduction in cancer incidence, morbidity or mortality rates. It is also expected that the activities in one area will complement those in the other areas, thereby creating a synergistic effect. To determine if the objectives of the Centre for Behavioral Research and Program Evaluation (CBRPE) are being met, the NCIC has committed to an ongoing assessment of the CBRPE's performance, including an independent review of its scientific merit by a site visit conducted at the end of the second year of the CBRPE's operation. Thus, while the behavioral initiative represents a different type of investment by the NCIC, its contributions will be judged via a process that is central to all NCIC activities--the assessment of scientific merit by teams of persons recognized nationally and internationally for their expertise in social and behavioral research as it pertains to cancer.
Download full-text PDF |
Source |
---|
Trop Med Int Health
March 2025
UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia.
Background: To demonstrate the application and utility of geostatistical modelling to provide comprehensive high-resolution understanding of the population's protective immunity during a pandemic and identify pockets with sub-optimal protection.
Methods: Using data from a national cross-sectional household survey of 6620 individuals in the Dominican Republic (DR) from June to October 2021, we developed and applied geostatistical regression models to estimate and predict Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) spike (anti-S) antibodies (Ab) seroprevalence at high resolution (1 km) across heterogeneous areas.
Results: Spatial patterns in population immunity to SARS-CoV-2 varied across the DR.
J Am Coll Cardiol
March 2025
Ciccarone Center for Prevention of Cardiovascular Disease, Johns Hopkins Medicine, Baltimore, Maryland, USA; American Heart Association Tobacco Regulation and Addiction Center, Dallas, Texas, USA. Electronic address:
Background: Cigarette smoking is a strong risk factor for cardiovascular harm.
Objectives: The study sought to explore the detailed relationships between smoking intensity, pack-years, and time since cessation with inflammation, thrombosis, and subclinical atherosclerosis markers of cardiovascular harm.
Methods: We included 182,364 participants (mean age 58.
Res Theory Nurs Pract
March 2025
Department of Population Health, College of Nursing, University of Cincinnati, Cincinnati, Cincinnati, OH 45221, USA.
Understanding and promoting healthy eating behaviors in young children is essential for their immediate and long-term health outcomes. However, these behaviors are influenced by an intricate network of factors that extend beyond individual choices, posing challenges for health practitioners seeking effective interventions. This article aims to explore how the Social Ecological Model (SEM) can serve as a framework for understanding the multilevel determinants of young children's eating behaviors, and the seminal role that nursing plays in this dynamic.
View Article and Find Full Text PDFPsychogeriatrics
May 2025
Integrated Research Initiative for Living Well with Dementia, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan.
Background: It is predicted that the number of older persons with dementia (PwD) living alone in Japan will increase in the future. Consequently, it is also expected that the number of missing older PwD living alone will rise. However, there is little research on missing PwD who live alone.
View Article and Find Full Text PDFVaccine
March 2025
Center for International Health, Education, and Biosecurity, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.
Background: To generate COVID-19 vaccine safety data in Nigeria, passive reporting was supplemented with cohort event monitoring (CEM), an active surveillance system. We described reactogenicity within 7 days and adverse events up to 3 months after each AstraZeneca or Moderna COVID-19 vaccine dose while assessing the feasibility of implementing CEM in a low- to middle-income country (LMIC) during a mass vaccination campaign.
Methods: Participants were aged ≥18 years with access to mobile phones who received the first dose of an authorized COVID-19 vaccine from participating health facilities in 6 states of Nigeria during September and October 2021.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!